News

05/08/2021

Sant Pau researchers advance in the knowledge of the most common chronic inflammatory neuropathy

Dr Elba Pascual-Goñi, researcher of the Neuromuscular Diseases Group of the Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau has described a new subgroup of patients with...

22/07/2021

The official COVIRNA project video is out

Sant Pau Biomedical Research Institute (IIB Sant Pau) is a partner in the COVIRNA project. The project aims to generate an innovative diagnostic tool to identify COVID-19 patients at risk of developin...

21/07/2021

New plasma biomarker to detect Alzheimer’s disease in Down syndrome individuals

International collaboration led by researchers at the Sant Pau Reseach Institute – IIB Sant Pau in Barcelona, Spain, shows effectiveness of a plasma biomarker to detect Alzheimer’s Disease in Down...

08/07/2021

Large genomic analysis highlights COVID-19 risk factors

An international collaboration uncovers several genetic markers associated with SARS-CoV-2 infection and COVID-19 severity. These results, which have been published in Nature, come from one of the la...

14/06/2021

New biomarkers in blood are identified for the prognosis of abdominal aortic aneurysm risk

Blood and vascular levels of various molecules related to oxidative stress can be good predictors of aneurysm rupture.  The research, developed by researchers from the Research Institute o...